5,7-Dihydroxy-2-(4-hydroxyphenyl)-6-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-8-((2S,3R,4S,5S)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)-4H-chromen-4-one
2-Cyano-3-(1-(3-(dimethylamino)propyl)-1H-indol-3-yl)-N-octylacrylamide
3-Hydroxy-N'-(2,4,5-trihydroxybenzylidene)-2-naphthohydrazide
N,N,N-Trimethyltetradecan-1-aminium bromide
3-(2,4-Dichloro-5-methoxyphenyl)-2-mercaptoquinazolin-4(3H)-one
N'-(3,4-Dihydroxybenzylidene)-3-hydroxy-2-naphthohydrazide
Rel-(1S,5R)-6-((5-(1H-pyrazol-3-yl)furan-2-yl)methyl)-3-((4-methyl-1H-imidazol-5-yl)methyl)-3,6-diazabicyclo[3.2.2]nonane
Clathrin-IN-4
DRP1i27 dihydrochloride
DynaMin inhibitory peptide, myristoylated
Dynamin IN-2
Bis-t-23
N-(4-(1H-Tetrazol-5-yl)phenyl)-4-methyl-1-((2-(piperidin-1-yl)thiazol-4-yl)methyl)-1H-pyrrole-2-carboxamide
DynaMin inhibitory peptide, myristoylated TFA
2-(1-(4-Chlorophenyl)cyclopropyl)-7-iodo-5-oxo-4,5-dihydropyrazolo[1,5-a]quinazoline-3-carbonitrile
Clathrin-IN-2
